Исследования и наука

Study: Supplement Plus Chemo Boosts Pancreatic Cancer Survival | Newswise - Newswise

Study: Supplement Plus Chemo Boosts Pancreatic Cancer Survival | Newswise Newswise

Natera teams with Angiex on cancer drug trial monitoring - Fierce Biotech

Natera teams with Angiex on cancer drug trial monitoring Fierce Biotech

Study: Supplement Plus Chemo Boosts Pancreatic Cancer Survival - Mega Doctor News

Study: Supplement Plus Chemo Boosts Pancreatic Cancer Survival Mega Doctor News

Savolitinib Combo Boosts PFS in First-Line EGFR-Mutant NSCLC Trial

A new drug targeting KRAS, one of the key drivers of pancreatic cancer, is raising hopes after promising trial results. Rasonque has been approved in the USA, with a price tag of nearly $39,800 a month. Here’s why doctors are excited and what it could mean f - linkedin.com

A new drug targeting KRAS, one of the key drivers of pancreatic cancer, is raising hopes after promising trial results. Rasonque has been approved in the USA, with a price tag of nearly $39,800 a month. Here’s why doctors are excited and what it could mean f linkedin.com

Dr. Tobias Janowitz joins Feinstein Institutes as new Institute of Cancer Research director - Business Wire

Dr. Tobias Janowitz joins Feinstein Institutes as new Institute of Cancer Research director Business Wire

Cancer trials: Early-stage disease is underrepresented in open protocols - verahealth.ai

Cancer trials: Early-stage disease is underrepresented in open protocols verahealth.ai

Xenograft Model Selection and Standardization Across CDX, PDX, Humanized, and Organoid-Derived Models in Preclinical Cancer Research - sg.finance.yahoo.com

Xenograft Model Selection and Standardization Across CDX, PDX, Humanized, and Organoid-Derived Models in Preclinical Cancer Research sg.finance.yahoo.com

Xenograft Model Selection and Standardization Across CDX, PDX, Humanized, and Organoid-Derived Models in Preclinical Cancer Research - Yahoo Finance

Xenograft Model Selection and Standardization Across CDX, PDX, Humanized, and Organoid-Derived Models in Preclinical Cancer Research Yahoo Finance

UMass Cancer Walk supports access to lifesaving clinical trials - UMass Chan Medical School

UMass Cancer Walk supports access to lifesaving clinical trials UMass Chan Medical School

Experience builds confidence when it comes to speaking at meetings

Take a look at the Healio | OSN calendar page, and you will find more than three dozen meetings, symposia and summits that make up a year of ophthalmology gatherings. Whether they are one-room, single-day conferences, such as Clinical Trials at the Summit, or they take up full convention centers, such as the American…

Unboxing Cancer News, August 2026: Fishy Cancer, Federal- vs. Industry-funded Trials, and More - American Association for Cancer Research (AACR)

Unboxing Cancer News, August 2026: Fishy Cancer, Federal- vs. Industry-funded Trials, and More American Association for Cancer Research (AACR)

David Sebag-Montefiore: Exciting Milestone for the STAR-TREC Rectal Cancer Trial - Oncodaily

David Sebag-Montefiore: Exciting Milestone for the STAR-TREC Rectal Cancer Trial Oncodaily

Alpha Tau Completes Patient Enrollment in its Multicenter IMPACT Pancreatic Cancer Pilot Study of Alpha DaRT® Following Strong Demand and Multiple Expansions - Alpha Tau Medical

Alpha Tau Completes Patient Enrollment in its Multicenter IMPACT Pancreatic Cancer Pilot Study of Alpha DaRT® Following Strong Demand and Multiple Expansions Alpha Tau Medical

Meet Tania Small, MD: A Force Behind The Fight For Cancer Research - essence.com

Meet Tania Small, MD: A Force Behind The Fight For Cancer Research essence.com